| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 22,157 | 16,010 | 10,841 | 21,511 | | Cost of Revenue | 12,148 | 9,198 | 6,088 | 11,707 | | | Gross Profit | 10,009 | 6,812 | 4,753 | 9,805 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 3,554 | 3,621 | 3,319 | 3,033 | | Non Recurring | 1,310 | 19 |
-
| (491) | | Others | 281 | 340 | 427 | (386) | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 4,864 | 2,832 | 1,007 | 7,648 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 801 | (1,211) | 334 | 410 | | Earnings Before Interest And Taxes | 5,665 | 1,621 | 1,342 | 8,058 | | Interest Expense | 793 |
-
|
-
|
-
| | Income Before Tax | 4,872 | 1,621 | 1,342 | 8,058 | | Income Tax Expense | 824 | 536 | 227 | 1,609 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 4,047 | 1,085 | 1,115 | 6,449 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 4,047 | 1,085 | 1,115 | 6,449 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $4,047 | $1,085 | $1,115 | $6,449 |
|
0.75% Nasdaq 
0.02 (0.28%) 
Income Statement
